BDBM38817 3-cyclohexyl-6-[4-(2-furoyl)piperazin-1-yl]pyrimidine-2,4(1H,3H)-dione::3-cyclohexyl-6-[4-(2-furoyl)piperazino]uracil::3-cyclohexyl-6-[4-(furan-2-carbonyl)piperazin-1-yl]-1H-pyrimidine-2,4-dione::3-cyclohexyl-6-[4-(furan-2-ylcarbonyl)piperazin-1-yl]-1H-pyrimidine-2,4-dione::3-cyclohexyl-6-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]-1H-pyrimidine-2,4-dione::MLS000094378::SMR000029964::cid_3237172

SMILES O=C(N1CCN(CC1)c1cc(=O)n(C2CCCCC2)c(=O)[nH]1)c1ccco1

InChI Key InChIKey=PMGMHDGOKGOPIA-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 38817   

TargetM-phase inducer phosphatase 2(Human)
University of Pittsburgh

Curated by PubChem BioAssay
LigandPNGBDBM38817(3-cyclohexyl-6-[4-(2-furoyl)piperazin-1-yl]pyrimid...)
Affinity DataIC50: 5.00E+4nMAssay Description:The Cdc25B Phosphatase HTS dose response confirmation has been developed to confirm actives identified in the Cdc25B HTS AID 368, screened at the Uni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2011
Entry Details
PCBioAssay